Trial Details
RECRUITINGBasic Information
| Clinical ID | c905 |
|---|---|
| Identifier | NCT05837897 |
| Trial Title | A Study of Vedolizumab in Adult Participants With Moderate to Severe Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: Vedolizumab IV|DRUG: Placebo |
Participant Information
| Sponsor | Takeda |
|---|---|
| City | Anhui |
| Country/Region | China |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2023-06-16 |
|---|---|
| Primary Completion Date | 2030-03-08 |
| Completion Date | 2031-05-30 |